Recent advances in targeted therapies in acute myeloid leukemia

Recent advances in targeted therapies in acute myeloid leukemia

Abstract Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell transplantation (alloHSCT), this effect...

Full description

Bibliographic Details
Main Authors: Rahul S. Bhansali, Keith W. Pratz, Catherine Lai
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Journal of Hematology & Oncology
Subjects:
Acute myeloid leukemia
Targeted therapy
Novel treatments
Combination therapy
FLT3
IDH1
Online Access:https://doi.org/10.1186/s13045-023-01424-6

Similar Items

Similar Items